source
- Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesRoche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune disea…Fierce Biotech · 8d ago↗ source
- FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.Fierce Biotech · 8d ago↗ source
- Vertex was sole bidder in high-premium Crinetics acquisitionAnalysts expect new details on the lead-up to the deal “are likely to reignite” investor scrutiny that Vertex overpaid in what’s poised to be its largest-ever transaction.